Zellis announced a definitive agreement to acquire elementsuite, an AI enabled HR software company. As part of the deal, elementsuite will be combined with Zellis, the largest provider of payroll and HR software to the UK and Ireland, creating an end-to-end AI-powered HR and Payroll platform.

Holly, an AI-based platform modernizing government hiring, announced the closing of its $2.2 million oversubscribed pre-seed round, led by J2 Ventures with participation from Roble Ventures, Gaingels, and prominent angel investors. This funding will support Holly's platform as it works to solve the million-job government workforce vacancy crisis.

Ouro Medicines, a biotechnology company creating immune reset therapeutics for people living with chronic immune-mediated diseases, announced its launch with $120 million in funding. And the company was launched by Monograph Capital in partnership with GSK plc. And the Series A funding round was co-led by TPG Life Sciences Innovations, NEA, and Norwest Venture Partners, with participation from Monograph Capital, GSK, UPMC Enterprises, Boyu/Zoo Capital, LongRiver Investments, and other unnamed investors.

Overhaul, an industry leader in active supply chain risk management and intelligence, announced the completion of $55 million in equity funding led by Springcoast Partners, with follow-on participation from existing investors Edison Partners and Americo. The growth investment from Springcoast will fuel Overhaul's continued advancements in AI and support its strategic acquisition roadmap.

Phase Four, a leader in advanced in-space propulsion design and manufacturing, announced the first closing of its Series C funding round. The company has secured nearly 60% of the target raise with strong participation from new and existing investors. The funding round was led by Artemis Group Capital, the Oklahoma-based investment firm helmed by former NASA Administrator Jim Bridenstine, underscoring the growing confidence in Phase Four's innovative propulsion solutions.

Timberlyne Therapeutics - a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders - announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-class monoclonal antibody targeting CD38, for diseases of high unmet medical needs. The funding was led by investors Abingworth, Bain Capital Life Sciences, and Venrock Healthcare Capital Partners, with participation from Boyu Capital, Lilly Asia Ventures, Braidwell LP, and 3H Health Investment.

First Ascent Biomedical, a pioneer in personalized cancer treatment, announced a $6 million investment from Vidal Duart Enterprises, with an additional co-investment from Techstars. The funding will accelerate First Ascent Biomedical’s mission to transform medical oncology with highly individualized, prospective treatment planning technologies that improve patient survival.

Farther, a leading technology-driven wealth management firm, announced it has welcomed SignalPoint Asset Management to its platform. And with about $650 million in client assets under management, SignalPoint represents Farther’s most significant partnership to date, solidifying its reputation as a rapidly growing RIA.

AccountsIQ, a leading provider of cloud-based accounting software, announced its acquisition of ExpenseIn. This expense management software empowers businesses to take control of their expense and invoice management process. And ExpenseIn, which joins the AccountsIQ Group and will continue trading with its existing name, shares AccountsIQ’s values and customer-centric approach.

Stellex Capital Management, a New York-based middle-market private equity firm, announced that it has completed an acquisition of Industrial Construction Services Holding (ICS), a leading provider of electrical services. The financial terms of the transaction were not disclosed.

Speyside Equity Advisers - a private equity firm that invests in middle-market, buyout transactions in the manufacturing and value-added distribution sectors - announced that it has completed the acquisition of GSC Technologies. The deal will enable Speyside's continued investment in GSC and fuel the company's next growth phase. GSC is a leading manufacturer of plastic goods in North America.

ControlMonkey, an end-to-end cloud automation platform offering "Total Cloud Control with Terraform," announced its global launch and the close of a $7 million seed round, co-led by lool ventures and Joule Ventures. This funding round will accelerate the development of ControlMonkey's cloud governance tools and expand its global operations, including significant investments in engineering, customer success, and go-to-market initiatives.

Rockfish Data, a leader in synthetic data generation for operational workflows, announced the closing of a $4 million seed fundraising round. This funding round was led by Emergent Ventures with participation from Foster Ventures, TEN13, Dallas VC, NewBuild Venture Capital, and others. This brings the total amount raised close to $6 million.

Electric vehicle (EV) merchandising solution Lyteflo announced $3 million in seed funding. Launched by Ryan Osten (CEO) and Dominick Rivard (CTO), Lyteflo seamlessly integrates into dealership websites to help auto dealers move their EV inventory faster and appraise EV batteries with precision: a one-stop shop to help dealerships win the electric future. And Diagram led the oversubscribed round, with participation from Whitecap Venture Partners and Amplify Capital.

Netradyne, a SaaS provider of artificial intelligence (AI) and edge computing, announced closing a $90 million Series D round led by Point72 Private Investments with participation from Qualcomm Ventures and Pavilion Capital. The funding will accelerate the company’s growth trajectory through strategic investment in R&D, enhanced go-to-market investments, and aggressive global expansion, solidifying Netradyne as a worldwide industry leader in commercial fleet technology.

Coram AI, an innovator in LLM-powered video security, announced it raised $13.8 million in Series A funding in a round led by Battery Ventures. And existing investors 8VC and Mosaic Ventures also participated in the round.

Leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity Health, announced the Truveta Genome Project, which is an innovative collaboration to generate genetic data on tens of millions of consented and de-identified volunteers, creating the largest and most diverse database of genotypic and phenotypic information ever assembled. For this initiative, 17 health systems, including Regeneron and Illumina, have invested $320 million in Truveta preferred equity at a valuation exceeding $1 billion. As part of this deal, Regeneron has made a strategic investment of $119.5 million upfront (as part of Truveta’s Series C financing round), enabling the advancement of discovery and development of new therapies and the development of next-generation solutions for healthcare delivery and population health management. And Illumina, a global leader in DNA sequencing and array-based technologies, will invest $20 million. This builds on the previously announced strategic investment Microsoft made into Truveta.

Reown (previously known as WalletConnect) announced it has closed a $13 million Series B funding round. USV and 1kx led the funding round and it also included Global Digital Asset Holdings (a joint venture investment vehicle established by SC Ventures and SBI Holdings), Shopify Ventures, Kraken Ventures, Crypto.com Capital, Figment, Kiln, Everstake, BitGo Ventures, and Fenbushi. So far, Reown has raised a total of $38 million from some of the most prominent investors in Web 2 and web3.

Light Horse Therapeutics - a developer of first-in-class small molecule therapeutics - announced a $62 million Series A funding round. This funding was led by founding investor Versant Ventures and included Mubadala Capital as well as three strategic investors: Bristol-Myers Squibb Co, Taiho Ventures, and AbbVie. And Light Horse is the latest company started by Versant’s Inception Discovery Engine, and its scientific co-founders are Brian Liau, PhD, Ben Cravatt, PhD, and Nathanael Gray, PhD.

eBay announced that it has agreed to acquire Caramel, an end-to-end online automotive transaction solution provider. Caramel's technology platform provides a secure and seamless digital transaction experience that handles all of the complexities of a vehicle sale, including paperwork, ownership transfer, financing, transportation, and more, whether using on Caramel's site or app, through an independent dealer, or via Caramel's multiple marketplace and auction partners.

Lead Ninja is a company that aims to elevate HVAC, plumbing, and electrical technicians and businesses by providing the tools, training, and strategies to get ahead of the competition. Pulse 2.0 interviewed Lead Ninja CEO Gene Slade to learn more about the company.

A few months ago, leading customer success platform Gainsight partnered with multinational software company SAP to deliver a powerful integration between Gainsight CS and SAP Sales Cloud. This integration helps businesses transform how they deliver value-driven customer experiences at scale to maximize customer retention and revenue growth. Pulse 2.0 interviewed Gainsight President and COO Chuck Ganapathi and SAP’s Senior Vice President of CX Solution Management Nitin Badjatia to learn more about their partnership.

Tide is transformative and true-zero-trust technology, enabling platform developers to lock their systems and grant access with keys no one will ever hold. Pulse 2.0 interviewed Tide co-founder Yuval Hertzog to learn more about the organization.

Mavely is a Social Commerce platform that unlocks trust between your brand and its target audience. Pulse 2.0 interviewed Mavely co-founder Evan Wray to learn more about the company.

Leading insurance technology platform Matic Insurance Services announced it has secured $30 million from Vistara Growth, a provider of flexible growth capital to software and technology enabled services companies. And Matic offers an embedded insurance platform to mortgage servicers, originators, banks and other financial institutions to seamlessly offer home, auto, and other personal lines products to their customers.

Neumirna Therapeutics - an RNA-focused biotech company developing next-generation therapeutics for neurological disorders - announced the first closing of its Series A funding round at €20 million. New investors Angelini Ventures and Invivo Partners co-led the funding, with significant participation from Neumirna’s seed investor, Innovestor’s Life Science Fund, and other investors.

Coave Therapeutics - a company advancing the future of genetic medicines - announced the raising of €32 million ($33 million) in Series A funding. The funding was co-led by Novo Holdings A/S and Bpifrance, with Invus and UI Investissement participation alongside existing investors Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital, and Turenne Capital.

KashKick is a consumer rewards program that engages its audience through game challenges, consumer product deals, and market research opportunities. Pulse 2.0 interviewed Kashkick co-founder and CEO Vishal Mahtani to learn more about the company.

Deep Vector, an AI-based platform for analyzing underwriting documents, announced it closed a seed round of $1.5 million, co-led by Aperture Venture Capital and InsurTech NY. And Deep Vector helps insurers and brokers translate the influx of analog documents used for underwriting risk: claims loss runs, Acord forms, motor vehicle records, and business records into usable and actionable data.

PrettyDamnQuick (PDQ), an operational data platform for profitable commerce, announced that it closed a $25 million Series A funding round led by Peakspan Capital, with participation from existing investors TLV Partners and Moneta. And PDQ will utilize the funds to expand its market presence and accelerate the development of its cutting-edge checkout and shipping personalization engine, which helps mid-sized Direct-to-Consumer (D2C) e-commerce brands to boost revenue and compete more effectively with massive global entities like Amazon. So far, PDQ has raised $38 million.